☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Companion Diagnostic
Chugai Receives MHLW's Approval for the Expanded Use of FoundationOne CDx as a Companion Diagnostic of Rozlytrek (entrectinib)
December 27, 2019
Myriad to File sPMA to the US FDA of BRACAnalysis CDx as a Companion Diagnostic for Lynparza (olaparib) to Treat Metastatic Castra...
August 8, 2019
Myriad Expands its Companion Diagnostic Collaboration with AstraZeneca and Merck
April 5, 2019
Load more...
Back to Home